{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:26:59Z","timestamp":1761514019887,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejim.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T15:46:47Z","timestamp":1496850407000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Occurrence of malignant neoplasia in patients with primary hyperparathyroidism"],"prefix":"10.1016","volume":"43","author":[{"given":"Serena","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Roggero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-3300","authenticated-orcid":false,"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.06.001_bb0005","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice. Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejim.2017.06.001_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.06.001_bb0015","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.06.001_bb0020","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.06.001_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/2230-8210.104042","article-title":"Hyperparathyroidism: cancer and mortality","volume":"16","author":"Goswami","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.06.001_bb0030","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperperathyroidism","volume":"14","author":"Hedback","year":"1990","journal-title":"World J Surg"},{"key":"10.1016\/j.ejim.2017.06.001_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcp.1040780305","article-title":"The roles of calcium and cyclic AMP in the stimulatory action of parathyroid hormone on thymic lymphocyte proliferation","volume":"78","author":"Whitfield","year":"1971","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejim.2017.06.001_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1054\/mehy.1999.0880","article-title":"Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D","volume":"54","author":"McCarty","year":"2000","journal-title":"Med Hypoths"},{"key":"10.1016\/j.ejim.2017.06.001_bb0045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bone.2007.11.017","article-title":"Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation","volume":"42","author":"Pettway","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.ejim.2017.06.001_bb0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/oxfordjournals.aje.a114879","article-title":"Increased risk of malignant diseases after surgery for primary hyperparathyroidism \u2013 a nationwide cohort study","volume":"127","author":"Palm\u00e9r","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejim.2017.06.001_bb0055","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/cncr.10846","article-title":"Hyperparathyroidism and subsequent cancer risk in Denmark","volume":"95","author":"Pickard","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2017.06.001_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","article-title":"Increased mortality in patients hospitalised with primary hyperparathyroidism during the period 1977\u20131993 in Denmark","volume":"28","author":"\u00d8gard","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.ejim.2017.06.001_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.1.01261","article-title":"The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy","volume":"14","author":"Nilsson","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejim.2017.06.001_bb0070","first-page":"1","article-title":"Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979","volume":"102","author":"Palm\u00e9r","year":"1987","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2017.06.001_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0039-6060(05)80076-5","article-title":"Parathyroid adenoma and the risk of death after treatment for primary hyperparathyroidism","volume":"117","author":"Hedb\u00e4ck","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2017.06.001_bb0080","first-page":"42","article-title":"Is primary hyperparathyroidism a risk factor for papillary thyroid cancer? An exemplar study and literature review","volume":"19","author":"Cinamon","year":"2015","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.ejim.2017.06.001_bb0085","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"S\u00f6reide","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2017.06.001_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2017.06.001_bb0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/j.ajkd.2015.04.042","article-title":"Onco-nephrology: core curriculum 2015","volume":"66","author":"Eric","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2017.06.001_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-13-0102","article-title":"Prevalence of subclinical contributors to low bone mineral density and\/or fragility fracture","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2017.06.001_bb0105","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40618-016-0434-8","article-title":"Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis","volume":"39","author":"Vescini","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejim.2017.06.001_bb0110","first-page":"896","article-title":"Prevention and screening in hereditary breast and ovarian cancer","volume":"30","author":"Zeichner","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ejim.2017.06.001_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrclinonc.2016.120","article-title":"Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?","volume":"14","author":"Klil-Drori","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejim.2017.06.001_bb0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2471\/BLT.09.064709","article-title":"Trends in smoking and quitting in China from 1993 to 2003: National Health Service Survey data","volume":"88","author":"Qian","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ejim.2017.06.001_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.17219\/acem\/42626","article-title":"Interdisciplinary aspects of primary hyperparathyroidism: symptomatology in a series of 100 cases","volume":"25","author":"Jodkowska","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.ejim.2017.06.001_bb0130","first-page":"1","volume":"17","year":"2000","journal-title":"NIH Consens Statement"},{"key":"10.1016\/j.ejim.2017.06.001_bb0135","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","article-title":"Osteoporosis in young adults: pathophysiology, diagnosis, and management","volume":"23","author":"Ferrari","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ejim.2017.06.001_bb0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ntr\/ntp010","article-title":"How should we define light or intermittent smoking? Does it matter?","volume":"11","author":"Husten","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.ejim.2017.06.001_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2016.870","article-title":"Guidelines for the diagnosis, prevention and management of osteoporosis","volume":"68","author":"Rossini","year":"2016","journal-title":"Reumatismo"},{"key":"10.1016\/j.ejim.2017.06.001_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.06.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","author":"Minisola","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.ejim.2017.06.001_bb0160","unstructured":"UpToDate calculator. In Calcium correction in hypoalbuminemia, version 18.2. Waltham, MA: Wolters Kluwer-Health (available at: www.uptodate.com), 2010."},{"key":"10.1016\/j.ejim.2017.06.001_bb0165","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semi-quantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ejim.2017.06.001_bb0170","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-014-2619-3","article-title":"Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis","volume":"25","author":"Cairoli","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ejim.2017.06.001_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejim.2014.01.001","article-title":"The relationship between secondary hyperparathyroidism and thyroid cancer in end stage renal disease: a population based cohort study","volume":"25","author":"Lin","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2017.06.001_bb0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10552-007-9001-0","article-title":"Serum calcium and breast cancer risk: results from a prospective cohort study of 7847 women","volume":"18","author":"Almquist","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejim.2017.06.001_bb0185","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1210\/jc.2013-4320","article-title":"Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.06.001_bb0190","first-page":"69","article-title":"Vitamin D receptor polymorphisms and cancer","volume":"810","author":"Gandini","year":"2014","journal-title":"Adv Exp Med Biol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517302297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:21:42Z","timestamp":1659079302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517302297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":38,"alternative-id":["S0953620517302297"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.06.001","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence of malignant neoplasia in patients with primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}